Gene · 81
Papers2,438
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,438
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A phase I study of autologous mesenchymal stromal cells for severe steroid-dependent nephrotic syndrome. | JCI Insight | 2023 | 37561590 | PubTator, text mining | PubMed |
| HMGB1 is involved in viral replication and the inflammatory response in coxsackievirus A16-infected 16HBE cells via proteomic analysis and identification. | Virol J | 2023 | 37559147 | PubTator, text mining | PubMed |
| Identification and validation of a novel anoikis-related signature for predicting prognosis and immune landscape in ovarian serous cystadenocarcinoma. | Heliyon | 2023 | 37554782 | PubTator, text mining | PubMed |
| The expression and prognostic value of disulfidptosis progress in lung adenocarcinoma. | Aging (Albany NY) | 2023 | 37552140 | PubTator, text mining | PubMed |
| Asiaticoside ameliorates renal ischemia/reperfusion injury by promoting CD4+CD25+FOXP3+ treg cell differentiation. | Heliyon | 2023 | 37539103 | PubTator, text mining | PubMed |
| Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex. | J Biol Chem | 2023 | 37536630 | PubTator, text mining | PubMed |
| Hepatic transcript profiling in beef cattle: Effects of rumen-protected niacin supplementation. | PLoS One | 2023 | 37535643 | PubTator, text mining | PubMed |
| Exploring the Molecular Targets for the Antidepressant and Antisuicidal Effects of Ketamine Enantiomers by Using Network Pharmacology and Molecular Docking. | Pharmaceuticals (Basel) | 2023 | 37513925 | PubTator, text mining | PubMed |
| Assessment of Therapeutic Potential of a Dual AAV Approach for Duchenne Muscular Dystrophy. | Int J Mol Sci | 2023 | 37511179 | PubTator, text mining | PubMed |
| Recent Advances in Proteinuric Kidney Disease/Nephrotic Syndrome: Lessons from Knockout/Transgenic Mouse Models. | Biomedicines | 2023 | 37509442 | PubTator, text mining | PubMed |
| State of the art in childhood nephrotic syndrome: concrete discoveries and unmet needs. | Front Immunol | 2023 | 37503337 | PubTator, text mining | PubMed |
| Human platelet lysate stimulates neurotrophic properties of human adipose-derived stem cells better than Schwann cell-like cells. | Stem Cell Res Ther | 2023 | 37480149 | PubTator, text mining | PubMed |
| SuPAR mediates viral response proteinuria by rapidly changing podocyte function. | Nat Commun | 2023 | 37479685 | PubTator, text mining | PubMed |
| Multi-omics in thoracic aortic aneurysm: the complex road to the simplification. | Cell Biosci | 2023 | 37475058 | PubTator, text mining | PubMed |
| A brief history of galectin evolution. | Front Immunol | 2023 | 37457740 | PubTator, text mining | PubMed |
| Unveiling Angiotensin II and Losartan-Induced Gene Regulatory Networks Using Human Urine-Derived Podocytes. | Int J Mol Sci | 2023 | 37445727 | PubTator, text mining | PubMed |
| Insights into the Role of LncRNAs and miRNAs in Glioma Progression and Their Potential as Novel Therapeutic Targets. | Cancers (Basel) | 2023 | 37444408 | PubTator, text mining | PubMed |
| A YAP/TAZ-ARHGAP29-RhoA Signaling Axis Regulates Podocyte Protrusions and Integrin Adhesions. | Cells | 2023 | 37443829 | PubTator, text mining | PubMed |
| An extensive study of potential inhibitors of extracellular vesicles release in triple-negative breast cancer. | BMC Cancer | 2023 | 37442985 | PubTator, text mining | PubMed |
| Wharton's jelly mesenchymal stem cells: a concise review of their secretome and prospective clinical applications. | Front Cell Dev Biol | 2023 | 37440921 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/81/papers?page=11